Interobserver Agreement of PD-L1/SP142 Immunohistochemistry and Tumor-Infiltrating Lymphocytes (TILs) in Distant Metastases of Triple-Negative Breast Cancer: A Proof-of-Concept Study. A Report on Behalf of the International Immuno-Oncology Biomarker Working Group

Autor: Carolien H M van Deurzen, Stefan Michiels, Roberto Salgado, M. Brinkhuis, Marleen Kok, Iris Nederlof, Dieter Peeters, Fabiola Giudici, Els Dequeker, John M. S. Bartlett, Mustimbo Roberts, Scott Ely, Pieter J. Westenend, Celine Vreuls, Mieke R Van Bockstal, Maxine Cooks, David L. Rimm, Hugo M. Horlings, Inne Nauwelaers, Loes F. S. Kooreman, Dimitrios Zardavas, Bert van der Vegt, Annemiek C. Dutman, Kalliopi P. Siziopikou, L.C. Verhoog, Carsten Denkert, Giuseppe Floris, Paul J. van Diest, Monique Koopmans, Balazs Acs, Nele Laudus, Johan Hartman

Publikováno v: Cancers, 13(19):4910. MDPI AG
Cancers
Cancers, Vol 13, Iss 4910, p 4910 (2021)
Van Bockstal, M R, Cooks, M, Nederlof, I, Brinkhuis, M, Dutman, A, Koopmans, M, Kooreman, L, Van Der Vegt, B, Verhoog, L, Vreuls, C, Westenend, P, Kok, M, Van Diest, P J, Nauwelaers, I, Laudus, N, Denkert, C, Rimm, D, Siziopikou, K P, Ely, S, Zardavas, D, Roberts, M, Floris, G, Hartman, J, Acs, B, Peeters, D, Bartlett, J M S, Dequeker, E, Salgado, R, Giudici, F, Michiels, S, Horlings, H & Van Deurzen, C H M 2021, ' Interobserver Agreement of PD-L1/SP142 Immunohistochemistry and Tumor-Infiltrating Lymphocytes (TILs) in Distant Metastases of Triple-Negative Breast Cancer: A Proof-of-Concept Study. A Report on Behalf of the International Immuno-Oncology Biomarker Working Group ', Cancers, vol. 13, no. 19, pp. 4910 . https://doi.org/10.3390/cancers13194910, https://doi.org/10.3390/cancers13194910
Cancers, Vol. 13, no. 19, p. 4910 [1-20] (2021)
Cancers, 13(19):4910. Multidisciplinary Digital Publishing Institute (MDPI)
Volume 13
Issue 19

Simple Summary: Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype that lacks significant expression of estrogen receptor, progesterone receptor, and HER2. Patients with locally advanced or metastatic TNBC benefit from treatm

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::110e200d33650dfbd0c601a89f230a75
https://research.rug.nl/en/publications/ac14eec3-150e-4afb-854b-dc6bbd121f3c